“By allowing researchers to actually see the nano scale structures they are working with, we help them improve speed and reduce risk in all phases of the drug development process, from discovery and characterization through approval and manufacturing,” said Clint Potter, CEO, NanoImaging Services. “This new facility will allow us to meet the rapidly growing demand we have seen already in our first four months of operation.”
NanoImaging benefited from early support and funding from Merck Capital Ventures, LLC, a subsidiary of Merck & Co., Inc., and FEI Company. The company’s new location is 10931 North Torrey Pines Road, # 108, San Diego, CA 92037 USA. For more information, please visit www.nanoimagingservices.com.
Editor Background
About NanoImaging Services
NanoImaging Services, Inc. provides transmission electron microscope imaging services to the pharmaceutical, biotechnology and nanotechnology industries, and specializes in the characterization of large biological molecules used in biopharmaceuticals such as vaccines, antibodies, cytokines, hormones and gene therapies. In contrast to conventional (small molecule) drugs, biopharmaceuticals are typically protein-based and manufactured in controlled, modified, biological systems. Their complexity and similarity to naturally occurring compounds makes a detailed understanding of their structure, and its relationship to their safety and efficacy, essential in their development and approval. Biopharmaceuticals represent an important and rapidly-growing segment of the pharmaceutical industry. For more information, visit www.nanoimagingservices.com.
